Stuart B. Rosenblum

1.2k total citations
23 papers, 725 citations indexed

About

Stuart B. Rosenblum is a scholar working on Immunology, Oncology and Organic Chemistry. According to data from OpenAlex, Stuart B. Rosenblum has authored 23 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Oncology and 8 papers in Organic Chemistry. Recurrent topics in Stuart B. Rosenblum's work include Chemokine receptors and signaling (7 papers), Immunotherapy and Immune Responses (6 papers) and Synthesis of β-Lactam Compounds (4 papers). Stuart B. Rosenblum is often cited by papers focused on Chemokine receptors and signaling (7 papers), Immunotherapy and Immune Responses (6 papers) and Synthesis of β-Lactam Compounds (4 papers). Stuart B. Rosenblum collaborates with scholars based in United States, United Kingdom and Switzerland. Stuart B. Rosenblum's co-authors include Adriano Afonso, Tram Huynh, Harry R. Davis, John W. Clader, Nathan Yumibe, Duane A. Burnett, Joseph A. Kozlowski, Ron Bihovsky, Jay S. Fine and Long Cui and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Stuart B. Rosenblum

22 papers receiving 690 citations

Peers

Stuart B. Rosenblum
Thais M. Sielecki United States
Stefan Jaroch Germany
Carol Torcellini United States
John Ramphal United States
Wayne Vaccaro United States
Robert A. Galemmo United States
Kenji Ohwaki Japan
Angela Seaton United Kingdom
Joachim Blanz Germany
Ameen Ghannam United States
Thais M. Sielecki United States
Stuart B. Rosenblum
Citations per year, relative to Stuart B. Rosenblum Stuart B. Rosenblum (= 1×) peers Thais M. Sielecki

Countries citing papers authored by Stuart B. Rosenblum

Since Specialization
Citations

This map shows the geographic impact of Stuart B. Rosenblum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart B. Rosenblum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart B. Rosenblum more than expected).

Fields of papers citing papers by Stuart B. Rosenblum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart B. Rosenblum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart B. Rosenblum. The network helps show where Stuart B. Rosenblum may publish in the future.

Co-authorship network of co-authors of Stuart B. Rosenblum

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart B. Rosenblum. A scholar is included among the top collaborators of Stuart B. Rosenblum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart B. Rosenblum. Stuart B. Rosenblum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rosenblum, Stuart B., et al.. (2024). Real-World Prescription Data for Intrathecal Drug Delivery: A Retrospective Analysis in 32,784 Patients. Neuromodulation Technology at the Neural Interface. 28(7). 1054–1058.
2.
Nair, Anilkumar G., Michael Wong, Youheng Shu, et al.. (2014). IV. Discovery of CXCR3 antagonists substituted with heterocycles as amide surrogates: Improved PK, hERG and metabolic profiles. Bioorganic & Medicinal Chemistry Letters. 24(4). 1085–1088. 12 indexed citations
3.
Zeng, Qingbei, Stuart B. Rosenblum, Zhaoxia Yang, et al.. (2013). Synthesis and SAR studies of benzimidazolone derivatives as histamine H3-receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 23(21). 6001–6003. 5 indexed citations
4.
Jenh, Chung‐Her, Mary Ann Cox, Long Cui, et al.. (2012). A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection. BMC Immunology. 13(1). 2–2. 74 indexed citations
5.
Velázquez, Francisco, Srikanth Venkatraman, Charles A. Lesburg, et al.. (2012). Synthesis of New 4,5-Dihydrofuranoindoles and Their Evaluation as HCV NS5B Polymerase Inhibitors. Organic Letters. 14(2). 556–559. 24 indexed citations
6.
Cox, Mary Ann, Long Cui, Eva‐Pia Reich, et al.. (2012). A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection. BMC Immunology. 13(1). 2–2. 73 indexed citations
7.
Shin, Yoo Seob, Katsuyuki Takeda, Hiroshi Ohnishi, et al.. (2011). Targeting CXCR3 reduces ligand-induced T-Cell activation but not development of lung allergic responses. Annals of Allergy Asthma & Immunology. 107(2). 145–153. 2 indexed citations
8.
Kim, Seong Heon, G. Anilkumar, Qingbei Zeng, et al.. (2011). III. Identification of novel CXCR3 chemokine receptor antagonists with a pyrazinyl–piperazinyl–piperidine scaffold. Bioorganic & Medicinal Chemistry Letters. 21(23). 6982–6986. 15 indexed citations
9.
Anilkumar, G., James W. Hall, Doug W. Hobbs, et al.. (2010). II. SAR studies of pyridyl–piperazinyl-piperidine derivatives as CXCR3 chemokine antagonists. Bioorganic & Medicinal Chemistry Letters. 21(5). 1527–1531. 16 indexed citations
10.
McGuinness, Brian, Doug W. Hobbs, James W. Hall, et al.. (2009). Novel CXCR3 antagonists with a piperazinyl-piperidine core. Bioorganic & Medicinal Chemistry Letters. 19(17). 5205–5208. 21 indexed citations
11.
Wang, Yuanfan, Long Cui, Waldemar Gonsiorek, et al.. (2009). CCR2 and CXCR4 regulate peripheral blood monocyte pharmacodynamics and link to efficacy in experimental autoimmune encephalomyelitis. Journal of Inflammation. 6(1). 32–32. 46 indexed citations
12.
Aslanian, Robert, Kevin D. McCormick, John J. Piwinski, et al.. (2002). Identification of a novel, orally bioavailable histamine H3 receptor antagonist based on the 4-benzyl-(1H-imidazol-4-yl) template. Bioorganic & Medicinal Chemistry Letters. 12(6). 937–941. 24 indexed citations
13.
Afonso, Adriano, Jay Weinstein, Joseph Kelly, et al.. (1999). Analogues of 1-(3,10-Dibromo-8-chloro-6,11-dihydro-5 H -benzo[5,6]-cyclohepta[1,2- b ]pyridin-11-yl)piperidine as inhibitors of farnesyl protein transferase. Bioorganic & Medicinal Chemistry. 7(9). 1845–1855. 8 indexed citations
14.
Wolin, Ronald, Joseph Kelly, Jay Weinstein, et al.. (1998). Inhibitors of farnesyl protein transferase. synthesis and biological activity of amide and cyanoguanidine derivatives containing a 5,11-dihydro[1]benzthiepin, benzoxepin, and benzazepin [4,3-b]pyridine ring system. Bioorganic & Medicinal Chemistry Letters. 8(18). 2521–2526. 12 indexed citations
15.
Afonso, Adriano, Stuart B. Rosenblum, Mohindar S. Puar, & Andrew T. McPhail. (1998). Beta-lactams derived from the reaction of phenanthridines and 11H-dibenzo[b,e]azepin-11-one with phenylvaleryl chloride. Synthesis of fused analogs of the cholesterol absorption inhibitor Sch 48461. Tetrahedron Letters. 39(41). 7431–7434. 14 indexed citations
16.
17.
Rosenblum, Stuart B., Tram Huynh, Adriano Afonso, et al.. (1998). Discovery of 1-(4-Fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)- hydroxypropyl]-(4S)-(4-hydroxyphenyl)-2-azetidinone (SCH 58235):  A Designed, Potent, Orally Active Inhibitor of Cholesterol Absorption. Journal of Medicinal Chemistry. 41(6). 973–980. 280 indexed citations
18.
Ginzberg, Idit, Stuart B. Rosenblum, Y. Koltin, & Nechama I. Smorodinsky. (1992). Neutralizing monoclonal antibodies against α and β subunits of theUstilago maydis virus encoded toxin. Virus Genes. 6(3). 273–280. 1 indexed citations
19.
Bates, Hans Aaron & Stuart B. Rosenblum. (1986). Nucleophilic displacements on an .alpha.-chloro thioether by organocuprates: a novel synthesis of desoxybiotin. The Journal of Organic Chemistry. 51(18). 3447–3451. 12 indexed citations
20.
Bates, Hans Aaron & Stuart B. Rosenblum. (1985). 300 Mhz 1H NMR spectra and conformations of biotin and related hexahydrothienoimidazolone derivatives. Tetrahedron. 41(12). 2331–2336. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thais M. Sielecki Breakdown of academic impact, for papers by Stefan Jaroch Breakdown of academic impact, for papers by Carol Torcellini Breakdown of academic impact, for papers by John Ramphal Breakdown of academic impact, for papers by Wayne Vaccaro Breakdown of academic impact, for papers by Robert A. Galemmo Breakdown of academic impact, for papers by Kenji Ohwaki Breakdown of academic impact, for papers by Angela Seaton Breakdown of academic impact, for papers by Joachim Blanz Breakdown of academic impact, for papers by Ameen Ghannam
Rankless by CCL
2026